These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26320437)

  • 1. Increasing Antimicrobial Resistance Monitored in Surveillance Analysis of Blood Stream Infections in Febrile Neutropenic Pediatric Oncology Patients.
    El-Mahallawy HA; Hassan SS; El-Wakil M; Moneer MM; Shalaby L
    Asian Pac J Cancer Prev; 2015; 16(14):5691-5. PubMed ID: 26320437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and laboratory parameter dynamics as markers of blood stream infections in pediatric oncology patients with fever and neutropenia.
    Hazan G; Ben-Shimol S; Fruchtman Y; Abu-Quider A; Kapelushnik J; Moser A; Falup-Pecurariu O; Greenberg D
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):e275-9. PubMed ID: 24276046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and microbiologic determinants of serious bloodstream infections in Egyptian pediatric cancer patients: a one-year study.
    El-Mahallawy H; Sidhom I; El-Din NH; Zamzam M; El-Lamie MM
    Int J Infect Dis; 2005 Jan; 9(1):43-51. PubMed ID: 15603994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-8 predicts pediatric oncology patients with febrile neutropenia at low risk for bacteremia.
    Cost CR; Stegner MM; Leonard D; Leavey P
    J Pediatr Hematol Oncol; 2013 Apr; 35(3):206-11. PubMed ID: 23425997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective multicenter study of microbiologically defined infections in pediatric cancer patients with fever and neutropenia: Swiss Pediatric Oncology Group 2003 fever and neutropenia study.
    Agyeman P; Kontny U; Nadal D; Leibundgut K; Niggli F; Simon A; Kronenberg A; Frei R; Escobar H; Kühne T; Beck-Popovic M; Bodmer N; Ammann RA
    Pediatr Infect Dis J; 2014 Sep; 33(9):e219-25. PubMed ID: 24618935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
    El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of C-reactive protein during febrile neutropenia in pediatric malignancies.
    Avabratha KS; Rau AT; Venkataravanamma P; Rau A
    Indian Pediatr; 2009 Sep; 46(9):797-9. PubMed ID: 19430077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased interleukin-10 levels correlate with bacteremia and sepsis in febrile neutropenia pediatric oncology patients.
    Urbonas V; Eidukaitė A; Tamulienė I
    Cytokine; 2012 Mar; 57(3):313-5. PubMed ID: 22189417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-year survey of bacteremia and fungemia in a pediatric intensive care unit.
    Gray J; Gossain S; Morris K
    Pediatr Infect Dis J; 2001 Apr; 20(4):416-21. PubMed ID: 11332667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prediction model for bacteremia and transfer to intensive care in pediatric and adolescent cancer patients with febrile neutropenia.
    Alali M; Mayampurath A; Dai Y; Bartlett AH
    Sci Rep; 2022 May; 12(1):7429. PubMed ID: 35523855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of IL-1 beta, sIL-2R, IL-6, IL-8, and TNF-alpha in febrile children with cancer and neutropenia.
    Soker M; Colpan L; Ece A; Devecioğlu C; Haspolat K
    Med Oncol; 2001; 18(1):51-7. PubMed ID: 11778970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
    Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
    Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance study of bacteraemic episodes in febrile neutropenic children.
    Ariffin H; Navaratnam P; Lin HP
    Int J Clin Pract; 2002 May; 56(4):237-40. PubMed ID: 12074201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia.
    Baorto EP; Aquino VM; Mullen CA; Buchanan GR; DeBaun MR
    Cancer; 2001 Aug; 92(4):909-13. PubMed ID: 11550165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Meropenem therapy in children with febrile neutropenia].
    Müller J; Kovács G; Garami M; Schmidt M; Fekete G
    Orv Hetil; 2003 Oct; 144(43):2115-20. PubMed ID: 14661443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approach to Non-Neutropenic Fever in Pediatric Oncology Patients-A Single Institution Study.
    Ali BA; Hirmas N; Tamim H; Merabi Z; Hanna-Wakim R; Muwakkit S; Abboud M; Solh HE; Saab R
    Pediatr Blood Cancer; 2015 Dec; 62(12):2167-71. PubMed ID: 26175012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The predictive value of soluble biomarkers (CD14 subtype, interleukin-2 receptor, human leucocyte antigen-G) and procalcitonin in the detection of bacteremia and sepsis in pediatric oncology patients with chemotherapy-induced febrile neutropenia.
    Urbonas V; Eidukaitė A; Tamulienė I
    Cytokine; 2013 Apr; 62(1):34-7. PubMed ID: 23510625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes simplex virus in febrile neutropenic children undergoing chemotherapy for cancer: a prospective cohort study.
    Ramphal R; Grant RM; Dzolganovski B; Constantin J; Tellier R; Allen U; Weitzman S; Matlow A; Petric M; Sung L
    Pediatr Infect Dis J; 2007 Aug; 26(8):700-4. PubMed ID: 17848881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients.
    Oude Nijhuis CSM; Vellenga E; Daenen SMGJ; van der Graaf WTA; Gietema JA; Groen HJM; Kamps WA; de Bont ESJM
    Intensive Care Med; 2003 Dec; 29(12):2157-2161. PubMed ID: 14569424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.